Source:http://linkedlifedata.com/resource/pubmed/id/10741739
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
2000-6-1
|
pubmed:abstractText |
Molecular genetic aberrations and the related phenotypes were investigated in 191 papillary thyroid carcinomas (PTCs) from patients exposed at young age to radioiodine released from the Chernobyl reactor. A high prevalence of RET gene rearrangements (62.3%) with a significant predominance of ELE1/RET (PTC3) over H4/RET (PTC1) rearrangements was found in PTCs of the first post-Chernobyl decade. NTRK1 rearrangements were rare (3.3%). In 3.3%, we observed novel types of RET rearrangements: GOLGA5/ RET (PTC5), HTIF/RET (PTC6), RFG7/RET (PTC7), and an as yet undefined RFGX/RET.RET rearrangements, preferentially ELE1/RET, are related to rapid tumor development. At longer intervals after exposure to ionizing radiation, the prevalence of RET rearrangements declines with a shift from ELE1/RET to H4/RET, most significantly in female patients. The prevalence of specific types of rearrangements is independent of age at irradiation. A significantly higher prevalence of ELE1/RET was observed in the most heavily contaminated Oblasts, Gomel and Brest, suggesting a preferential formation of this type of rearrangement after high thyroid doses. RET rearrangement is related to aggressive growth: Rearrangement-positive PTCs were in a more advanced pT category and more frequently in the pN1 category at presentation than rearrangement-negative PTCs. ELE1/RET is related to the solid variant of PTC, H4/RET more frequently to typical papillary structures. The genotype/phenotype evaluation of post-Chernobyl PTCs reveals a characteristic spectrum of gene rearrangements that lead to typical phenotypes with important biological and clinical implications.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Drosophila Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Proto-Oncogene Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Proto-Oncogene Proteins c-ret,
http://linkedlifedata.com/resource/pubmed/chemical/Receptor, trkA,
http://linkedlifedata.com/resource/pubmed/chemical/Receptor Protein-Tyrosine Kinases,
http://linkedlifedata.com/resource/pubmed/chemical/Ret oncogene protein, Drosophila
|
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
1078-0432
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
6
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1093-103
|
pubmed:dateRevised |
2009-11-19
|
pubmed:meshHeading |
pubmed-meshheading:10741739-Adolescent,
pubmed-meshheading:10741739-Age Factors,
pubmed-meshheading:10741739-Carcinoma, Papillary,
pubmed-meshheading:10741739-Child,
pubmed-meshheading:10741739-Child, Preschool,
pubmed-meshheading:10741739-Cohort Studies,
pubmed-meshheading:10741739-Dose-Response Relationship, Radiation,
pubmed-meshheading:10741739-Drosophila Proteins,
pubmed-meshheading:10741739-Female,
pubmed-meshheading:10741739-Gene Rearrangement,
pubmed-meshheading:10741739-Genetic Variation,
pubmed-meshheading:10741739-Genotype,
pubmed-meshheading:10741739-Humans,
pubmed-meshheading:10741739-Infant,
pubmed-meshheading:10741739-Infant, Newborn,
pubmed-meshheading:10741739-Male,
pubmed-meshheading:10741739-Neoplasm Staging,
pubmed-meshheading:10741739-Neoplasms, Radiation-Induced,
pubmed-meshheading:10741739-Phenotype,
pubmed-meshheading:10741739-Proto-Oncogene Proteins,
pubmed-meshheading:10741739-Proto-Oncogene Proteins c-ret,
pubmed-meshheading:10741739-Radioactive Hazard Release,
pubmed-meshheading:10741739-Receptor, trkA,
pubmed-meshheading:10741739-Receptor Protein-Tyrosine Kinases,
pubmed-meshheading:10741739-Sex Factors,
pubmed-meshheading:10741739-Thyroid Neoplasms,
pubmed-meshheading:10741739-Time Factors
|
pubmed:year |
2000
|
pubmed:articleTitle |
Pattern of radiation-induced RET and NTRK1 rearrangements in 191 post-chernobyl papillary thyroid carcinomas: biological, phenotypic, and clinical implications.
|
pubmed:affiliation |
Institute of Pathology, Ludwig-Maximilians-University, Munich, Germany. hm.rabes@lrz.uni-muenchen.de
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|